Press releases

Press Releases

IFFIm increases its most recent bond by US$ 250 million to total US$ 1 billion

18 Nov 2021

IFFIm today increased by US$ 250 million the 1% 5-year vaccine bond it issued in April 2021. The additional proceeds will provide Gavi, the Vaccine Alliance, immediately available funding to support routine immunisation in lower-income countries.  

Monique Barbut, Hassatou N’Sele and Ingrid van Wees to join IFFIm Board of Directors

01 Jul 2021

New board members bring diverse backgrounds in global development and finance London, 1 July 2021 – IFFIm, the International Finance Facility for Immunisation, has appointed three new global development and finance executives to its Board of Directors.  Monique Barbut, President of World Wildlife Fund (WWF) France, Hassatou Diop N’Sele, Treasurer...

IFFIm Returns to Market with US$ 750 Million 5-year Oversubscribed Vaccine Bonds

14 Apr 2021

IFFIm today priced US$ 750 million, 5-year fixed rate Vaccine Bonds that will provide Gavi, the Vaccine Alliance with immediately available funding to support routine immunisation in lower-income countries. The issuance, which is IFFIm’s second largest ever, will also accelerate the availability of critical funding for the Gavi COVAX Advance Market...

Italy reaffirms support of Gavi and CEPI with €5 million grant to IFFIm

26 Jan 2021

Italy’s new grant will provide immediate funding for CEPI’s COVID-19 vaccine research and development programme.

IFFIm Appoints Kenneth Lay as Chair of its Board of Directors

29 Oct 2020

Lay succeeds Cyrus Ardalan, who introduced CEPI programme and led successful replenishment raising over US$ 926 million.

IFFIm Prices US$500 Million 3-year Benchmark Vaccine Bonds

29 Oct 2020

IFFIm today priced US$ 500 million, 3-year fixed rate benchmark Vaccine Bonds that will provide Gavi, the Vaccine Alliance, flexible funding for its core immunisation programmes and efforts to develop and distribute eventual COVID-19 vaccines to countries around the world, particularly the poorest.

IFFIm issues NOK 2 billion in Vaccine Bonds for COVID-19 vaccine development

07 Jul 2020

IFFIm has issued NOK 2 billion in Vaccine Bonds to accelerate the availability of financing for urgent COVID-19 vaccine research and development by the Coalition for Epidemic Preparedness Innovations.